New biomarker may guide best use of KRAS inhibitors in lung cancer
Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib
This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alternative or combination therapies
TTF-1 is a readily available biomarker commonly used for lung cancer diagnostics
Researchers from Â鶹ӳ»...
MD Anderson breaks ground on new Sugar Land location
Â鶹ӳ» MD Anderson Cancer Center today broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range...
MD Anderson Research Highlights for January 22, 2025
Â鶹ӳ» MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
Â鶹ӳ» MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the senior vice president of people, culture and infrastructure, as well as the chief academic officer, she will spearhead initiatives that prioritize employee well-being, professional fulfillment...
MD Anderson expands arts experience program to enhance healing and well-being for patients
As part of its ongoing commitment to patient comfort and healing, Â鶹ӳ» MD Anderson Cancer Center today announced a new...